*Co-first author

#Senior author

Hartner S*, Abolfathi H*, Rezanejad M, Liu B, Karimi E, Rogers D, Sorin M, Doré S, Desharnais L, Orain M, Enlow W, Gagné A, Wei Y, Bossé Y, Quail D, Joubert P#, Walsh LA#. Oncogenic driver mutations underlie the spatial tumour immune landscape of non-small cell lung cancer. Nat Commun. 2025;16(1), 8402

Gagné A,  Alessi JVM, Ricciuti B, Lamberti G, Awad MM, Sholl LM#. Acquired SMARCA4 alterations: An uncommon contributor to cancer progression in lung adenocarcinomas. Lung Cancer. 2025;206:108644

Driussi A, Lamaze FC, Kordahi M, Saavedra Armero V, Gaudreault N, Orain M, Enlow W, Abbosh C, Hodgson D, Dasgupta A, Gagné A, Bossé Y, Joubert P#. Clinicopathological Predictors of the Presence of Blood Circulating Tumor DNA in Early-Stage Non–Small Cell Lung Cancers. Modern Pathology. 2025;38(6): 100744.

Kordahi M, Gagné A, Abolfathi H, Orain M, Couture C, Desmeules P, Trahan S, Pagé S, Vaucher J, Nicodème F, Conti M, Ugalde Figueroa P, Laliberté AS, Lamaze FC, Bossé Y, Joubert P#. Impact of Implementing a Grossing Tumor-margin Distance Threshold for Frozen Section in Oncologic Lung Surgery. Am J Surg Pathol. 2025;49(2):169-175.

Sorin M, Rezanejad M, Karimi E, Fiset B, Desharnais L, Perus LJM, Milette S, Yu MW, Maritan SM, Doré S, Pichette É, Enlow W, Gagné A, Wei Y, Orain M, Manem VSK, Rayes R, Siegel PM, Camilleri-Broët S, Joubert P#, Walsh LA#. Single-cell spatial landscapes of the lung tumour immune microenvironment. Nature. 2023;614(7948):548-554.

H Asamura, KK Nishimura, DJ Giroux, K Chansky, A Hoering, V Rusch, et al. IASLC lung cancer staging project: the new database to inform revisions in the ninth edition of the TNM classification of lung cancer. Journal of Thoracic Oncology. 2023;18(5), 564-575

Zhang T, Joubert P, Ansari-Pour N, Zhao W, Hoang PH, LokangaR, et al. Genomic and evolutionary classification of lung cancer in never smokers. Nature genetics. 2021;53(9), 1348-1359

Gagné A, Wang E, Bastien N , Orain M, Desmeules P, Pagé S, Trahan S, Couture C, Joubert D, Joubert P#. Impact of specimen characteristics on PD-L1 testing in non–small cell lung cancer: validation of the IASLC PD-L1 testing recommendations. Journal of Thoracic Oncology. 2019;14(12):2062-2070.